Bone marrow immune cells and drug resistance in acute myeloid leukemia

被引：0
|
作者：
Zhang, Miao [1 ,2 ]
Yang, You [1 ,2 ]
Liu, Jing [1 ,2 ]
Guo, Ling [1 ,2 ]
Guo, Qulian [1 ,2 ]
Liu, Wenjun [1 ,2 ]
机构：
[1] Southwest Med Univ, Affiliated Hosp, Dept Pediat Hematol Oncol, Children Hematol Oncol & Birth Defects Lab, Luzhou, Sichuan, Peoples R China
[2] Southwest Med Univ, Sichuan Clin Res Ctr Birth Defects, Affiliated Hosp, Luzhou, Sichuan, Peoples R China
来源：
EXPERIMENTAL BIOLOGY AND MEDICINE | 2025年 / 250卷
关键词：
leukemia; immune cells; drug resistance; bone marrow; immunosuppressive microenvironment; REGULATORY T-CELLS; SUPPRESSOR-CELLS; DENDRITIC CELLS; POOR-PROGNOSIS; NK CELLS; AML CELLS; IN-VITRO; EXPRESSION; ACTIVATION; INDUCTION;
D O I：
10.3389/ebm.2025.10235
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
In recent years, the relationship between the immunosuppressive niche of the bone marrow and therapy resistance in acute myeloid leukemia (AML) has become a research focus. The abnormal number and function of immunosuppressive cells, including regulatory T cells (Tregs) and myeloid-derived suppressor cells (MDSCs), along with the dysfunction and exhaustion of immunological effector cells, including cytotoxic T lymphocytes (CTLs), dendritic cells (DCs) and natural killer cells (NKs), can induce immune escape of leukemia cells and are closely linked to therapy resistance in leukemia. This article reviews the research progress on the relationship between immune cells in the marrow microenvironment and chemoresistance in AML, aiming to provide new ideas for the immunotherapy of AML.
引用
收藏
页数：17
相关论文
共 50 条
  • [31] Bone marrow adipocytes induce cancer-associated fibroblasts and immune evasion, enhancing invasion and drug resistance
    Sato, Shinya
    Hiruma, Toru
    Koizumi, Mitsuyuki
    Yoshihara, Mitsuyo
    Nakamura, Yoshiyasu
    Tadokoro, Hiroko
    Motomatsu, Sadako
    Yamanaka, Takashi
    Washimi, Kota
    Okubo, Yoichiro
    Yoshioka, Emi
    Kasajima, Rika
    Yamashita, Toshinari
    Kishida, Takeshi
    Yokose, Tomoyuki
    Miyagi, Yohei
    CANCER SCIENCE, 2023, 114 (06) : 2674 - 2688
  • [32] Acute Myeloid Leukaemia in Its Niche: the Bone Marrow Microenvironment in Acute Myeloid Leukaemia
    Ladikou, E. E.
    Sivaloganathan, H.
    Pepper, A.
    Chevassut, T.
    CURRENT ONCOLOGY REPORTS, 2020, 22 (03)
  • [33] Bone marrow hyaluronan distribution in patients with acute myeloid leukemia
    Gunnel Sundström
    Inger Marie S. Dahl
    Magnus Hultdin
    Berith Lundström
    Anders Wahlin
    Anna Engström-Laurent
    Medical Oncology, 2005, 22 : 71 - 78
  • [34] Bone marrow hyaluronan distribution in patients with acute myeloid leukemia
    Sundström, G
    Dahl, IMS
    Hultdin, M
    Lundström, B
    Wahlin, A
    Engström-Laurent, A
    MEDICAL ONCOLOGY, 2005, 22 (01) : 71 - 78
  • [35] miR-144-3p Derived from Bone Marrow Mesenchymal Stem Cells (BMSCs) Restrains the Drug Resistance of Acute Myeloid Leukemia (AML)
    Wu, Jun
    Xie, Yingying
    Han, Limei
    JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING, 2022, 12 (08) : 1525 - 1529
  • [36] Disruption of gap junctions attenuates acute myeloid leukemia chemoresistance induced by bone marrow mesenchymal stromal cells
    Kouzi, Farah
    Zibara, Kazem
    Bourgeais, Jerome
    Picou, Frederic
    Gallay, Nathalie
    Brossaud, Julie
    Dakik, Hassan
    Roux, Benjamin
    Hamard, Sophie
    Le Nail, Louis-Romee
    Hleihel, Rita
    Foucault, Amelie
    Ravalet, Noemie
    Rouleux-Bonnin, Florence
    Gouilleux, Fabrice
    Mazurier, Frederic
    Bene, Marie C.
    Akl, Haidar
    Gyan, Emmanuel
    Domenech, Jorge
    El-Sabban, Marwan
    Herault, Olivier
    ONCOGENE, 2020, 39 (06) : 1198 - 1212
  • [37] Increased cellular glutathione and protection by bone marrow stromal cells account for the resistance of non-acute promylocytic leukemia acute myeloid leukemia cells to arsenic trioxide in vivo
    Lee, CC
    Lin, YY
    Huang, MJ
    Lin, CP
    Liu, CR
    Chow, J
    Liu, HE
    LEUKEMIA & LYMPHOMA, 2006, 47 (03) : 521 - 529
  • [38] Mimicking the Acute Myeloid Leukemia Niche for Molecular Study and Drug Screening
    Houshmand, Mohammad
    Soleimani, Masoud
    Atashi, Amir
    Saglio, Giuseppe
    Abdollahi, Mohammad
    Zarif, Mahin Nikougoftar
    TISSUE ENGINEERING PART C-METHODS, 2017, 23 (02) : 72 - 85
  • [39] Immune Biology of Acute Myeloid Leukemia: Implications for Immunotherapy
    Khaldoyanidi, Sophia
    Nagorsen, Dirk
    Stein, Anthony
    Ossenkoppele, Gerrit
    Subklewe, Marion
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (05) : 419 - +
  • [40] Bone marrow overexpression of SNAI1 is an early indicator of intrinsic drug resistance in patients with de novo acute myeloid leukemia
    Gouda, Mahmoud B. Y.
    Hassan, Naglaa M.
    Kandil, Eman I.
    JOURNAL OF GENE MEDICINE, 2023, 25 (05):
12345